QA: ImmunoGen Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000855654_2018_ImmunoGen_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000855654, ImmunoGen Inc.

  xvar xval
0 AssetsCurrent 276,341,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 14,538,000
3 remainder_Assets 3,797,000
4 LiabilitiesCurrent 55,770,000
5 LiabilitiesNoncurrent 4,236,000
6 remainder_Liabilities 252,565,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 33,911,000
9 ResearchAndDevelopmentExpense 139,739,000
10 remainder_Expenses 40,416,000
11 remainder_Revenues 115,447,000
12 remainder_NetIncome 2,607,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 294,676,000
1 Liabilities 312,571,000
2 Expenses 214,066,000
3 Revenues 115,447,000
4 StockholdersEquity -17,895,000
5 NetIncome -96,012,000
6 ComprehensiveNetIncome -96,012,000
7 BaseVar 469,683,500
8 EconomicCapitalRatio -0.418

Edgar->Model Mapping

Feature Distribution

Change over Time